Investment Type: Venture Capital
Investment Stage: Seed; Series A; Series C
Portfolio 34
| Date | Name | Website | Total Raised | Location |
| 26.12.2024 | Axonis | axonis.us | $120M | United Sta... |
| 26.12.2024 | atbtherape... | atbtherapeutics.com | $57.22M | Belgium, L... |
| 25.03.2024 | Insamo | insamo.com | $12M | - |
| 27.11.2023 | VectorY | vectorytx.com | $178.32M | Netherland... |
| 17.05.2023 | Ray Therap... | raytherapeutics.com | $110M | United Sta... |
| 02.05.2023 | Anavo Ther... | anavotx.com | $85.32M | Netherland... |
| 27.04.2023 | Therini Bi... | therinibio.com | $53M | United Sta... |
| 16.09.2022 | Invivyd | invivyd.com | - | United Sta... |
| 07.09.2022 | Photys | photys.com | $75M | United Sta... |
| 07.09.2022 | Ambagon Th... | ambagontx.com | $84.91M | United Sta... |
Show more
Mentions in press and media 2
| Date | Title | Description |
| 13.06.2024 | InduPro Announces $85 Million Series A Financing, Appoints Prakash Raman, Ph.D. as CEO to Advance Next-Generation, Proximity-Based Protein Therapeutics for the Treatment of Cancer and Autoimmune Disea... | Developing therapeutics against novel, tumor-selective targets and co-target pairs using bispecific antibodies Series A proceeds fund advancement of the Company's lead programs to clinical readiness and the identification of additional cand... |
| 03.05.2023 | Dutch-based Anavo Therapeutics secures €8.5M to systematically drug phosphatases: Know more | Leiden-based Anavo Therapeutics, a company that claims to be the first to systematically drug phosphatases – a rich target space previously considered undruggable for decades, announced that it has raised €8.5M in a Seed extension round of ... |